PH
62
2
CMA
70
5
AVGO
54
12
CMI
71
2
IP
28
-3
MUR
36
3
THC
47
2
UNM
65
-7
COP
47
3
FFIV
47
-3
HRL
23
-12
AIZ
78
2
STZ
42
-2
OI
47
-11
RCL
68
4
NI
65
-2
ALL
56
2
CI
48
-4
F
59
3
DD
45
-7
PH
62
2
CMA
70
5
AVGO
54
12
CMI
71
2
IP
28
-3
MUR
36
3
THC
47
2
UNM
65
-7
COP
47
3
FFIV
47
-3
HRL
23
-12
AIZ
78
2
STZ
42
-2
OI
47
-11
RCL
68
4
NI
65
-2
ALL
56
2
CI
48
-4
F
59
3
DD
45
-7
Financhill
Back

Rafarma Pharmaceuticals, Inc. 10K Form

Sell
31

RAFA
Rafarma Pharmaceuticals, Inc.

Last Price:
$0.0300
Seasonality Move:
-4.21%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RAFA News And Ratings

See the #1 stock for the next 7 days that we like better than RAFA

RAFA Financial Statistics

Sales & Book Value

Annual Sales: $9.1M
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 0.24

Profitability

Net Income (TTM): $0
Gross Margin: $674K
Return on Equity: 0%
Return on Assets: 0%

Rafarma Pharmaceuticals, Inc. Earnings Forecast

Key Rafarma Pharmaceuticals, Inc. Financial Ratios

  • The Gross Profit Margin over the past 4 years for RAFA is 7.42%.
  • The Selling, General & Administrative Expenses for RAFA have been equal to 1.63% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of RAFA is 2.93% of Total Revenues.
  • Per Share Earnings over the last 4 years have been positive in 0 years.

Rafarma Pharmaceuticals, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Current Symbol: RAFA
Website: rafarma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 10
Forward P/E Ratio: 0

RAFA Technical Analysis vs Fundamental Analysis

Sell
31
Rafarma Pharmaceuticals, Inc. (RAFA) is a Sell

Is Rafarma Pharmaceuticals, Inc. a Buy or a Sell?